INFORMACIONES PSIQUIÁTRICAS 253

48 Informaciones Psiquiátricas 2024 - n.º 253 Older Adults. Research Quarterly for Exercise and Sport 1999; 70: 113 - 119. 26. Vite W, Temple VA. A clinical test of stepping and change of direction to identify multiple falling older adults. Arch Phys Med Rehabil 2002; 83: 1566 - 1571. 27. Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud 1991: 13: 50 - 54. 28. Floriach Robert M, Soriano Garcia S y Ruíz Idiago JM. Escala de valoración del control consciente del movimiento en la enfermedad de Huntington (CCM - HD). Informaciones Psiquiátricas 2021; 244:9 - 25. 29. Reisberg B, Ferris SH, de León MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. American Journal of Psychiatry 1982; 139:1136 - 1139. 30. Asociación Americana de Psiquiatría. Guía de consulta de los criterios diagnósticos del DSM 5. Arlington, VA, Asociación Americana de Psiquiatría, 2013. 31. NCD Risk Factor Collaboration (NCDRisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017 Dec 16; 390:2627 - 2642. 32. Wyant KJ, Ridder AJ, Dayalu P. Huntington’s Disease – Update on Treatments. Curr Neurol Neurosci Rep 2017; 17: 33. 33. Ferguson MW, Kennedy CJ, Palpagama TH, Waldvogel HJ, Faull RLM, Kwakowsky A. Current and Possible Future Therapeutic Options for Huntington's Disease. J Cent Nerv Syst Dis. 2022; 21:14. 34. McCusker E and Loy CT. Medical management of motor manifestations of Huntington’s disease. En Huntington Disease. Series Volume Editors: Andrew S. Feigin AS and Anderson KE (2017). Handbook of Clinical Neurology (pp 141 – 150). Editorial Elsevier. Dra. Misericòrdia Floriach i Robert

RkJQdWJsaXNoZXIy MzkyOTU=